Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Rebecca E. Risbon"'
Publikováno v:
Journal of the American Veterinary Medical Association. 252(4)
OBJECTIVE To describe signalment, clinicopathologic features, and outcomes of dogs with confirmed primary intestinal lymphoma and assess factors associated with survival times in these patients. DESIGN Retrospective case series. ANIMALS 84 client-own
Autor:
Rebecca E. Risbon, M.A. Arkans, B.M. Britton, J. Lachowicz, C.A. Manley, K. R. Vickery, Craig A. Clifford, Kristine Burgess, David M. Vail, C.D. Sammarco, C.M. Mullin
Publikováno v:
Veterinary and Comparative Oncology. 14:e171-e183
Sixty-four dogs were treated with single-agent doxorubicin (DOX) for presumptive cardiac hemangiosarcoma (cHSA). The objective response rate (CR + PR) was 41%, and the biologic response rate (CR + PR + SD), or clinical benefit, was 68%. The median pr
Autor:
Jeff C Philibert, Sheri Siegel, Kara Zivin, Eric J Bulakowski, Craig A. Clifford, Kim L Cronin, Rebecca E. Risbon
Publikováno v:
Journal of the American Veterinary Medical Association. 233:122-128
Objective—To evaluate outcome associated with subcutaneous and intramuscular hemangiosarcomas treated with adjuvant doxorubicin in dogs. Design—Retrospective case series. Animals—21 dogs. Procedures—Records of dogs with histologically confirm
Autor:
Rebecca E. Risbon, Christine M. Mullin, S. J. Mehler, Craig A. Clifford, L. P. De Lorimier, Michelle A. Morges, S. A. Kahn, E. D. Gouldin, L. May, C. Oakley
Publikováno v:
Veterinary and comparative oncology. 15(2)
The aim of this retrospective study was to evaluate the outcome of cats treated with surgical intervention for a discrete intermediate-/high-grade gastrointestinal lymphoma prior to CHOP-based chemotherapy. Variables including sex, breed, haematocrit
Autor:
J. W. Wojcieszyn, Craig A. Clifford, Kristine Burgess, Philip J. Bergman, J.A. Impellizeri, Kenneth J. Drobatz, Rebecca E. Risbon, Katherine A Skorupski, K. Hahn, J. Carreras, Michelle Turek, R. M. Fred, L. P. De Lorimier, Amy K. LeBlanc
Publikováno v:
Journal of veterinary internal medicine. 20(6)
Background:Epitheliotropic lymphoma (ELSA) is an uncommon cutaneous canine malignancy of T lymphocytes. A consensus regarding the therapeutic standard of care is lacking, warranting evaluation of chemotherapeutic agents traditionally employed against